{"title":"Covid-19: A Review about One of the Worst Known Pandemics of the Century","authors":"C. Das","doi":"10.36648/1989-8436.11.4.121","DOIUrl":null,"url":null,"abstract":"The current outbreak of the novel coronavirus SARSCOV-2 known as COVID-19 is one of the biggest known pandemics to have occurred. Much of the information regarding the SARS-COV 2 has been obtained owing to its similarities to the SARS virus. The spike proteins of the virus attack the ACE 2 receptors present mainly in the respiratory tract. The human body reacts vigorously to the infection by releasing a vast amount of interferon and interleukins which transform into a cytokine storm leading to an acute respiratory distress syndrome. Studies show that people with comorbidities are subject to a greater risk of catching the infection. A large section of these people has underlying cardiovascular diseases and blood pressure. An interesting hypothesis about ACE inhibitors possibly up regulating the ACE 2 receptors and exposing patients to a greater risk is also being studied upon. While the search for a vaccine for COVID-19 is ongoing, convalescent plasma therapy has emerged as an effective therapy for severely affected patients. Anti-viral drugs such as chloroquine, hydroxychloroquine, and remdesivir are also being tried as potential medications. Scientists have advised the intake of vitamin C and vitamin D in adequate doses daily, as studies have shown patients taking these vitamin supplements have lesser risks to catching pneumonia. This review article takes a deep look at how the SARS-COV 2 virus works, its primary symptoms while also briefing about the prophylaxis and medications.","PeriodicalId":8142,"journal":{"name":"Archives of Clinical Microbiology","volume":"35 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Clinical Microbiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36648/1989-8436.11.4.121","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The current outbreak of the novel coronavirus SARSCOV-2 known as COVID-19 is one of the biggest known pandemics to have occurred. Much of the information regarding the SARS-COV 2 has been obtained owing to its similarities to the SARS virus. The spike proteins of the virus attack the ACE 2 receptors present mainly in the respiratory tract. The human body reacts vigorously to the infection by releasing a vast amount of interferon and interleukins which transform into a cytokine storm leading to an acute respiratory distress syndrome. Studies show that people with comorbidities are subject to a greater risk of catching the infection. A large section of these people has underlying cardiovascular diseases and blood pressure. An interesting hypothesis about ACE inhibitors possibly up regulating the ACE 2 receptors and exposing patients to a greater risk is also being studied upon. While the search for a vaccine for COVID-19 is ongoing, convalescent plasma therapy has emerged as an effective therapy for severely affected patients. Anti-viral drugs such as chloroquine, hydroxychloroquine, and remdesivir are also being tried as potential medications. Scientists have advised the intake of vitamin C and vitamin D in adequate doses daily, as studies have shown patients taking these vitamin supplements have lesser risks to catching pneumonia. This review article takes a deep look at how the SARS-COV 2 virus works, its primary symptoms while also briefing about the prophylaxis and medications.